USA - New York Stock Exchange - NYSE:WST - US9553061055 - Common Stock
The current stock price of WST is 236.66 USD. In the past month the price decreased by -14.71%. In the past year, price decreased by -31.4%.
ChartMill assigns a fundamental rating of 7 / 10 to WST. WST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 7.07. The EPS increased by 4.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.29% | ||
| ROA | 11.98% | ||
| ROE | 16.11% | ||
| Debt/Equity | 0.07 |
22 analysts have analysed WST and the average price target is 354.05 USD. This implies a price increase of 49.6% is expected in the next year compared to the current price of 236.66.
For the next year, analysts expect an EPS growth of 6.29% and a revenue growth 6.25% for WST
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
WEST PHARMACEUTICAL SERVICES
530 Herman O. West Drive
Exton PENNSYLVANIA 19341 US
CEO: Eric M. Green
Employees: 10600
Phone: 16105942900
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
The current stock price of WST is 236.66 USD. The price decreased by -4.49% in the last trading session.
WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.81.
WST has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
The next ex-dividend date for WEST PHARMACEUTICAL SERVICES (WST) is January 28, 2026.
WEST PHARMACEUTICAL SERVICES (WST) currently has 10600 employees.
You can find the ownership structure of WEST PHARMACEUTICAL SERVICES (WST) on the Ownership tab.